Neoadjuvant therapy is an essential part of high-risk stage III resectable melanoma management, with combination ...

Eli Lilly & Co. is asking people who took copies of its blockbuster weight loss drug to give the company access to their ...

Two new papers by a team of researchers at Boston University, the Indiana University School of Medicine and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and the German Center for ...

Drugmaker Eli Lilly on Wednesday urged a federal appeals court to overturn a $183 million judgment against it in a case ...

As weight-loss treatments dominate the pharmaceutical market, Swiss drugmaker Novartis AG (SWX: NOVN) is choosing a different ...

INDIANAPOLIS–The U.S. Food and Drug Administration has approved Eli Lilly’s new treatment for moderate to severe eczema. It’s ...

OrbiMed Advisors LLC, a prominent investment firm, executed a significant transaction by acquiring an additional 6,807,336 shares of Terns Pharmaceuticals Inc (NASDAQ:TERN). This purchase was made at ...

Grace College made sure the ribbon-cutting for its Center for Literacy and Learning included a key component – books.

We recently compiled a list of the 10 Unstoppable Dividend Stocks to Buy. In this article, we will have a look at where Eli ...

Lilly has exclusive rights for development and commercialization of EBGLYSS in the U.S. and the rest of the world outside Europe. Lilly's partner Almirall S.A. has licensed the rights to develop and ...